Akèy › Metiyè › Chemists › Watertown, MA
Chemists nan Watertown, MA: Salè H-1B
24 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Watertown, MA. Salè baz medyàn ofri $117,206; mwatye mitan $105,851–$139,375.
Demann (LCA)24
Salè medyan ofri$117,206
Mwatye salè yo$105,851–$139,375
10yèm–90yèm pousantaj$97,984–$174,619
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $81,600 |
| Nivo II (kalifye) | $105,851 |
| Nivo III (eksperyans) | $124,093 |
| Nivo IV (plen kompetans) | $176,799 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Tome Biosciences Inc. | 4 | $90,800 |
| Foghorn Therapeutics, Inc | 4 | $117,312 |
| Novo Nordisk, Inc. | 3 | $198,187 |
| Orna Therapeutics, Inc. | 3 | $150,900 |
| C4 Therapeutics, Inc. | 2 | $142,792 |
| Enanta Pharmaceuticals, Inc. | 2 | $116,917 |
| Parallel Squared Technology Institute, LLC | 2 | $115,000 |
| Disc Medicine, Inc. | 1 | $137,500 |
| EyePoint Pharmaceuticals US, Inc. | 1 | $120,000 |
| Prime Medicine, Inc. | 1 | $140,000 |
| Souffle Therapeutics, Inc. | 1 | $97,760 |
Tit travay
- Senior Research Associate, Analytical Development4
- Associate Director, Formulation Development2
- Senior Scientist2
- Mass Spectrometry Scientist II2
- Scientist2
- Principal Research Associate2
- Senior Research Scientist1
- Scientist II Small Molecule CMC (OSDs)1
- Sr Associate Scientist1
- Senior Scientist - Process Chemistry1
- Scientist II, Oligonucleotide Chemistry1
- Associate Director - Quality Control1
- Associate Scientist II, Peptide Chemistry1
- Principal Scientist1
- Associate Scientist1
Pwonse H-1B nan Watertown, MA →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).